鲁索替尼乳膏(Ruxolitinib cream)在中国上市了吗?好购买吗

Introduction: Ruxolitinib Cream (Ruxolitinib The launch of Cream) in the Chinese market has brought good news to many patients with skin diseases. This article will briefly introduce the launch status of ruxolitinib cream in China, how to purchase it, as well as its main ingredients and mechanism of action.

Ruxolitinib cream is available in China and how to purchase it

It has been successfully launched in China. You can purchase ruxolitinib cream through the following channels:

Hospital pharmacy: Patients can go to the dermatology clinic of a regular hospital for treatment. The doctor will issue a prescription according to the condition and purchase it directly at the hospital pharmacy.

Online pharmacies: With the rise of e-commerce platforms, more and more online pharmacies have begun selling prescription drugs. Patients can purchase ruxolitinib cream with a doctor's prescription at legally qualified online pharmacies.

The main ingredients and mechanism of action of ruxolitinib cream

Main ingredients: The main ingredient of ruxolitinib cream is Ruxolitinib, a powerful Janus kinase (JAK) inhibitor. The JAK family is a group of non-receptor tyrosine kinases that participate in the signal transduction of a variety of cytokines and have an important impact on immunity and hematopoietic function. In addition to ruxolitinib, the cream may contain other excipients to ensure the stability and suitability of the drug.

Mechanism of action: Ruxolitinib cream exerts its therapeutic effect by inhibiting the JAK signaling pathway. Specifically, ruxolitinib can block the activity of JAK family members such as JAK1 and JAK2, thereby inhibiting the phosphorylation and activation of downstream signal transducers and activators of transcription (STATs). This inhibitory effect can reduce the production and release of inflammatory cytokines, thereby reducing the inflammatory response and immune response, and achieving the purpose of treating skin diseases.

In skin diseases such as atopic dermatitis and vitiligo, inflammatory response and immune response are important factors leading to the exacerbation of the disease. Ruxolitinib cream can significantly improve patients' symptoms and quality of life by inhibiting these pathological processes. In patients with atopic dermatitis, ruxolitinib cream can reduce symptoms such as itching, rash and redness; in patients with vitiligo, it can promote the restoration of skin pigment and improve the appearance of the skin.